Results 21 to 30 of about 104,178 (284)

Imaging of Pancreatic Neuroendocrine Neoplasms [PDF]

open access: yesInternational Journal of Environmental Research and Public Health, 2021
Pancreatic neuroendocrine neoplasms (panNENs) represent the second most common pancreatic tumors. They are a heterogeneous group of neoplasms with varying clinical expression and biological behavior, from indolent to aggressive ones. PanNENs can be functioning or non-functioning in accordance with their ability or not to produce metabolically active ...
Giuditta Chiti   +9 more
openaire   +4 more sources

Spectrum of neuroendocrine neoplasms of GIT – a histomorphological study in a tertiary care centre

open access: yesJournal of Medical Science, 2023
Background. Neuroendocrine neoplasms are diverse in terms of sites of origin, functional status, and degrees of aggressiveness. Since neuroendocrine cells are ubiquitous in the human body, these neoplasms can arise in different organs, with ...
Aparna Muralidhar, Pushpa Mahadevan
doaj   +1 more source

Medical treatment of neuroendocrine neoplasms [PDF]

open access: yes, 2021
Medical therapy of clinically nonfunctioning (nonsecreting) low grade (grade 1–2) neuroendocrine neoplasms consists of first-line first generation somatostatin analogs and second-line or third-line peptide receptor radiotherapy with radiolabeled beta ...
de Herder, Wouter W.   +2 more
core   +1 more source

Neoplastic signatures: Comparative proteomics of canine hepatobiliary neuroendocrine tumors to normal niche tissue.

open access: yesPLoS ONE, 2023
Hepatobiliary neuroendocrine neoplasms are rare cancers in humans and dogs. To date, no large-scale primary hepatobiliary neoplasm omics analyses exist in any species.
Tifini L Batts   +9 more
doaj   +1 more source

Neuroendocrine Neoplasms of the Ear [PDF]

open access: yesHead and Neck Pathology, 2018
Neuroendocrine neoplasms of the ear are uncommon primary tumors. There is a reported debate in the literature as to the true nature of these tumors and how to classify them. However, there is a kind of consensus that they can represent a spectrum of a common entity with dual glandular and neuroendocrine differentiation.
openaire   +2 more sources

Neuroendocrine neoplasms of the stomach [PDF]

open access: yesBiomedical Papers, 2014
Gastric neuroendocrine neoplasms of type 1 and type 3 are different entities and as such require different therapeutical strategies. The aim of this study was to define and distinguish these two tumour subtypes with clearly different biological properties and patient survival.
openaire   +2 more sources

Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

open access: yes, 2020
The nomenclature and classification of pancreatic neuroendocrine neoplasms has evolved in the last 15 years based on the advances in knowledge of the genomics, clinical behaviour and response to therapies.
Lam, Alfred King-Yin, Ishida, Hirotaka
core   +1 more source

Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification

open access: yes, 2022
Pancreatic neuroendocrine neoplasms (PanNENs) are the neuroendocrine neoplasms with greatest rate of increase in incidence. Approximately 10% of PanNENs arise as inherited tumour syndromes which include multiple endocrine neoplasia type 1, multiple ...
Lam, Alfred King-yin, Ishida, Hirotaka
core   +1 more source

Neuroendocrine Neoplasms of the Gut

open access: yes, 2020
Neuroendocrine neoplasms of the gut are a heterogeneous group of tumors showing different morphological, clinical, prognostic, and molecular features. Currently, these proliferations are classified as “neuroendocrine neoplasms” (NENs), which include two ...
Rindi, Guido   +5 more
core   +1 more source

A rectal neuroendocrine neoplasm

open access: yesRevista Española de Enfermedades Digestivas, 2017
The incidence of gastric and rectal carcinoids is increasing. This is probably due to endoscopic screening. The prognosis is primarily dependent upon tumor size, aggressiveness (pathology, Ki-67), metastatic disease and stage. However, neuroendocrine carcinoma usually behaves as an adenocarcinoma.
Varas-Lorenzo, Modesto J.   +1 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy